Skip to main content
Toggle navigation
Search
Home
Gold
Home
Gold
Gold
Type here to filter the list
(14) Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program
(76) Retention Rates Across Clinical Trials of Anti-CGRP Monoclonal Antibodies for Migraine Prevention
(80) Healthcare resource utilization and costs among individuals with narcolepsy and idiopathic hypersomnia in the United States
(89) Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention
(136) Unmasking Alternative Funding Programs- Patient Outcomes and Prescription Journey
(153) Pharmacist-Led Interventions in Comprehensive Medication Management: Impact on 90-Day Post-Discharge A1c Levels
(206) The timing and characteristics of supplemental indications for small and large molecule medicines
(210) Navigating artificial intelligence in evidence synthesis: A scoping review of current and developing guidelines
(309) Systematic Literature Review of Healthcare Resource Use (HCRU), Costs and Health-Related Quality of Life (HRQoL) for Brexucabtagene autoleucel in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) and Precursor B-cell lymphoblastic leukemia (B-ALL)
(362) Real-world characteristics and treatment patterns of patients with major depressive disorder initiating dextromethorphan-bupropion extended-release tablets, cariprazine, brexpiprazole, or esketamine
(364) Real-world healthcare utilization and costs associated with using dextromethorphan-bupropion extended-release tablets versus branded comparators for the treatment of major depressive disorder
(373) Real-World Visual Outcomes by Healthcare Insurance with Prescription Digital Treatment for Amblyopia: PUPiL Registry Analysis
(390) An Analysis of solid tumor oncology patients’ respiratory vaccination rates in accordance with ASCO guidelines
